BioSpace News Archive

The Primary Ciliary Dyskinesia Foundation (PCDF) has engaged Prometheus Research to deliver the informatics expertise and core technology that will empower the PCDF to accelerate its mission to advance research, diagnosis, care, and ultimately, find a cure for PCD.

The newly validated test detects and identifies seven Shiga toxin-producing strains of E. coli (STEC) known to cause severe human illness.

Integrity Marketing Group, LLC (“Integrity”), the nation’s largest independent distributor of life and health insurance products to the Senior Market, today announced it has acquired American Investment Strategies (“AIS”), an insurance marketing organization headquartered in Ohio.

The shareholder meeting, not to be confused with a shareholder conference call, will be held at the Courtyard by Marriott in Irvine, California, and will begin at 11:00 a.m. Pacific Daylight Time.

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest spend analysis engagement for a medical equipment company.

Pfizer announced today an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina.

The global Hemophilia A therapeutics market size is poised to grow by USD 4.31 billion during 2019-2023, according to a new report by Technavio, progressing at a CAGR of close to 7% during the forecast period.

Laerdal Medical achieves a breakthrough in service by providing clients access to an all new how-to video library

The American Foundation for the Blind (AFB) has received a $100,000 grant from American Express to launch the Blind Leaders Development Program, specifically targeted at blind and low vision people who are already employed and in the beginning stages of their careers.

CVS Health Corporation announced the applicable Reference Yields and Total Consideration to be paid in connection with the previously announced cash tender offers for up to $723,339,000 aggregate principal amount of its Floating Rate Notes due 2020 and its 2.800% Senior Notes due 2020 and up to $961,648,000 aggregate principal amount of its 3.350% Senior Notes due 2021, its Floating Rate Notes due 2021 and its 2.125% Senior Notes due 2021.